Other
Lease Payments
West Pharmaceutical Services Lease Payments decreased by 8.6% to $6.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $6.10M to $6.40M.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Consistent or rising cash payments indicate stable or growing operational footprint requirements.
Detailed definition
This reflects the actual cash outflow associated with operating lease liabilities. It is a key component of cash flow fr...
Peer comparison
Standard cash flow disclosure required for companies with significant real estate or equipment lease portfolios.
Metric ID:
cvx_operating_lease_payments_cashHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.10M | $2.90M | $3.20M | $3.10M | $3.70M | $4.90M | $5.00M | $4.50M | $5.30M | $15.00M | $6.00M | $6.10M | $6.50M | $7.00M | $6.40M |
| QoQ Change | — | -6.5% | +10.3% | -3.1% | +19.4% | +32.4% | +2.0% | -10.0% | +17.8% | +183.0% | -60.0% | +1.7% | +6.6% | +7.7% | -8.6% |
| YoY Change | — | — | — | +0.0% | +27.6% | +53.1% | +61.3% | +21.6% | +8.2% | +200.0% | +33.3% | +15.1% | -56.7% | +16.7% | +4.9% |
Range$2.90M – $15.00M
CAGR+23.0%
Avg YoY Growth+32.1%
Median YoY Growth+19.1%
Lease Payments at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's lease payments?
- West Pharmaceutical Services (WST) reported lease payments of $6.40M in Q1 2026.
- How has West Pharmaceutical Services's lease payments changed year-over-year?
- West Pharmaceutical Services's lease payments increased by 4.9% year-over-year, from $6.10M to $6.40M.
- What does lease payments mean?
- The cash paid to cover operating lease obligations.